Description
Pediatric TB Specialist Dr. Ira Shah talks about Pediatric Multi Drug-Resistant Tuberculosis. Drug Resistance is considered a potential obstacle for the elimination of TB globally and it is important for us to keep ourselves updated with the new updates.
Key discussion include
- New tests Xpert MTB/RIF Ultra and NAAT tests
- Treatment of MDRTB - Classes of drugs, Delamanid, Bedaquillin, New guidelines
- Case Discussion
- Problems - Pill burden, Cost, Safety, Side effects
- Aminoglycosides and toxicity
- DR TB Wadia Drug-Resistant TB - Type, Cases, demographic, Disease Site, Outcomes
- Case Discussion
- Conclusion